VivoSim Labs (VIVS) Operating Margin Growth (1y) (2012 - 2026)
VivoSim Labs (VIVS) Operating Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -1,651.00 |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | -744,940.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -744,940.00 |
| Mar 31, 2026 | -178,319.00 |
| Dec 31, 2025 | 387,308.00 |
| Sep 30, 2025 | -71,738.00 |
| Jun 30, 2025 | 80,367.00 |
| Mar 31, 2025 | 449,155.00 |
| Dec 31, 2024 | 5.92 Mn |
| Jun 30, 2024 | -308,872.00 |
| Mar 31, 2024 | -587,401.00 |
| Dec 31, 2023 | -7.10 Mn |
| Mar 31, 2023 | -467,432.00 |
| Dec 31, 2019 | -91,864.00 |
| Sep 30, 2019 | 8,218.00 |
| Jun 30, 2019 | 12,351.00 |
| Mar 31, 2019 | -36,699.00 |
| Dec 31, 2018 | -15,179.00 |
| Sep 30, 2018 | 6,972.00 |
| Jun 30, 2018 | -6,941.00 |
| Mar 31, 2018 | 63,001.00 |
| Dec 31, 2017 | 15,080.00 |